EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Characterization of a Novel FVB-PrkdcR2140C Mouse Model for Adriamycin-Induced Nephropathy

Masaki Watanabe, Yuki Ishii, Kazuki Hashimoto, Hayato R Takimoto, Nobuya Sasaki iD

Genes · 04.04.2024 · 15 (4) · 456

DOI: 10.3390/genes15040456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 04.04.2024. Verfasst von Masaki Watanabe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Japan. Hauptthemen laut MEDLINE: Doxorubicin, Disease Models, Animal, Kidney Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Adriamycin (ADR) nephropathy model, which induces podocyte injury, is limited to certain mouse strains due to genetic susceptibilities, such as the PrkdcR2140C polymorphism. The FVB/N strain without the R2140C mutation resists ADR nephropathy. Meanwhile, a detailed analysis of the progression of ADR nephropathy in the FVB/N strain has yet to be conducted. Our research aimed to create a novel mouse model, the FVB-PrkdcR2140C, by introducing PrkdcR2140C into the FVB/NJcl (FVB) strain. Our study showed that FVB-PrkdcR2140C mice developed severe renal damage when exposed to ADR, as evidenced by significant albuminuria and tubular injury, exceeding the levels observed in C57BL/6J (B6)-PrkdcR2140C. This indicates that the FVB/N genetic background, in combination with the R2140C mutation, strongly predisposes mice to ADR nephropathy, highlighting the influence of genetic background on disease susceptibility. Using RNA sequencing and subsequent analysis, we identified several genes whose expression is altered in response to ADR nephropathy. In particular, Mmp7, Mmp10, and Mmp12 were highlighted for their differential expression between strains and their potential role in influencing the severity of kidney damage. Further genetic analysis should lead to identifying ADR nephropathy modifier gene(s), aiding in early diagnosis and providing novel approaches to kidney disease treatment and prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDisease Models, AnimalKidney DiseasesAnimalsMiceMaleMice, Inbred C57BLGenetic Predisposition to DiseasePodocytes

Stichwörter der Autor:innen

AdriamycinFVB/NPrkdcchronic kidney diseasegenetic backgroundmousenephropathy

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Japan.

ORCID-Profile: Nobuya Sasaki

Zitieren

APA

Watanabe, M., Ishii, Y., Hashimoto, K., Takimoto, H. R., & Sasaki, N. (2024). Development and Characterization of a Novel FVB-PrkdcR2140C Mouse Model for Adriamycin-Induced Nephropathy. Genes, 15(4), 456. https://doi.org/10.3390/genes15040456

Vancouver

Watanabe M, Ishii Y, Hashimoto K, Takimoto HR, Sasaki N. Development and Characterization of a Novel FVB-PrkdcR2140C Mouse Model for Adriamycin-Induced Nephropathy. Genes. 2024;15(4):456. doi:10.3390/genes15040456

BibTeX
@article{Watanabe2024,
  author = {Watanabe, Masaki and Ishii, Yuki and Hashimoto, Kazuki and Takimoto, Hayato R and Sasaki, Nobuya},
  title = {Development and Characterization of a Novel FVB-PrkdcR2140C Mouse Model for Adriamycin-Induced Nephropathy},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {4},
  pages = {456},
  doi = {10.3390/genes15040456}
}
Kostenlos starten →